RARRES2 promotes glycolytic reprogramming and malignant phenotypes in clear cell renal cell carcinoma

Дата публикации: 20-10-2026 04:02:28

An article created on 2026-10-20 04:02:28

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	ASCC1 Promotes Malignant Progression of Pancreatic Cancer by Regulating the NF-κB Signaling Pathway	0	25.79	20-10-2026
2	Lineage plasticity and tumor microenvironment transcriptional features define a novel aggressive state in pediatric rhabdomyosarcoma	0	14.76	20-10-2026
3	Resistance of breast cancer stem cells to TROP2-targeted CAR-T therapy via the NF-κB signaling pathway	0	29.05	20-10-2026
4	A Novel ACLY Inhibitor Induces Transcriptional and Metabolic Reprogramming to Overcome Tyrosine kinase inhibitor Resistance in Lymphoma	0	13.31	20-10-2026
5	Intratumoral influenza A virus infection drives platinum resistance and invasive reprogramming in NSCLC	0	15.26	21-10-2026
6	Establishment and validation of prognostic nomogram for young adults with Non-Metastatic Renal Cell Carcinoma	0	20	20-08-2026
7	Illuminating Innate-Like T-Cell Signaling: From Signaling Architecture to Rational Cancer Immunotherapy	0	25.47	21-10-2026
8	An Interferon-Responsive Cancer-Associated Fibroblast Subtype Shapes an Immune-Active Tumor Microenvironment and Favors Survival in Ovarian Cancer	0	24.79	20-10-2026
9	Computationally guided inhibition of the HIF-1α–CBP/p300 coactivator interface suppresses hypoxia signaling in Caki-1 renal carcinoma cells	0	14.55	20-10-2026

Классификация: Информация. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 13.96. Источник: www.researchsquare.com.